{"title":"Drug-Target Interaction Prediction By Combining Transformer and Graph Neural Networks","authors":"Junkai Liu, Yaoyao Lu, Shixuan Guan, Tengsheng Jiang, Yijie Ding, Qiming Fu, Zhiming Cui, Hongjie Wu","doi":"10.2174/1574893618666230912141426","DOIUrl":null,"url":null,"abstract":"Background: The prediction of drug-target interactions (DTIs) plays an essential role in drug discovery. Recently, deep learning methods have been widely applied in DTI prediction. However, most of the existing research does not fully utilize the molecular structures of drug compounds and the sequence structures of proteins, which makes these models unable to obtain precise and effective feature representations. Methods: In this study, we propose a novel deep learning framework combining transformer and graph neural networks for predicting DTIs. Our model utilizes graph convolutional neural networks to capture the global and local structure information of drugs, and convolutional neural networks are employed to capture the sequence feature of targets. In addition, the obtained drug and protein representations are input to multi-layer transformer encoders, respectively, to integrate their features and generate final representations. Results: The experiments on benchmark datasets demonstrated that our model outperforms previous graph-based and transformer-based methods, with 1.5% and 1.8% improvement in precision and 0.2% and 1.0% improvement in recall, respectively. The results indicate that the transformer encoders effectively extract feature information of both drug compounds and proteins. Conclusion: Overall, our proposed method validates the applicability of combining graph neural networks and transformer architecture in drug discovery, and due to the attention mechanisms, it can extract deep structure feature data of drugs and proteins.","PeriodicalId":10801,"journal":{"name":"Current Bioinformatics","volume":"85 1","pages":"0"},"PeriodicalIF":2.4000,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574893618666230912141426","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The prediction of drug-target interactions (DTIs) plays an essential role in drug discovery. Recently, deep learning methods have been widely applied in DTI prediction. However, most of the existing research does not fully utilize the molecular structures of drug compounds and the sequence structures of proteins, which makes these models unable to obtain precise and effective feature representations. Methods: In this study, we propose a novel deep learning framework combining transformer and graph neural networks for predicting DTIs. Our model utilizes graph convolutional neural networks to capture the global and local structure information of drugs, and convolutional neural networks are employed to capture the sequence feature of targets. In addition, the obtained drug and protein representations are input to multi-layer transformer encoders, respectively, to integrate their features and generate final representations. Results: The experiments on benchmark datasets demonstrated that our model outperforms previous graph-based and transformer-based methods, with 1.5% and 1.8% improvement in precision and 0.2% and 1.0% improvement in recall, respectively. The results indicate that the transformer encoders effectively extract feature information of both drug compounds and proteins. Conclusion: Overall, our proposed method validates the applicability of combining graph neural networks and transformer architecture in drug discovery, and due to the attention mechanisms, it can extract deep structure feature data of drugs and proteins.
期刊介绍:
Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth/mini-reviews, research papers and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science.
The journal focuses on advances in computational molecular/structural biology, encompassing areas such as computing in biomedicine and genomics, computational proteomics and systems biology, and metabolic pathway engineering. Developments in these fields have direct implications on key issues related to health care, medicine, genetic disorders, development of agricultural products, renewable energy, environmental protection, etc.